Commitments and Contingencies (Details Narrative) - USD ($) $ in Thousands	May 31, 2022	Sep. 30, 2022
Kem Pharm [Member]
Product Liability Contingency [Line Items]
Cash consideration from sale of assets	$ 12,800
Liabilities assumed	$ 5,200
Aldoxorubicin [Member]
Product Liability Contingency [Line Items]
Milestone payment, amount		$ 1,000
Aldoxorubicin [Member] | Maximum [Member]
Product Liability Contingency [Line Items]
Milestone payment, amount		7,500
Arimoclomol [Member]
Product Liability Contingency [Line Items]
Milestone payment, amount		3,650
Innovive [Member]
Product Liability Contingency [Line Items]
Future earnout merger consideration		$ 18,300